Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021

10 May 2021 This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020. This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considerations on vaccine certificates or “passports” will be covered in an update of WHO interim guidance, as requested by the COVID-19 emergency committee

In May 2020, the World Health Assembly in resolution WHA73.1 requested the Director-General of the World Health Organization (WHO) to continue to work closely with the World Organisation for Animal Health (OIE), the Food and Agriculture Organization of the United Nations (FAO) and countries, as part of the One Health approach, to identify the zoonotic source of the virus and the route of introduction to the human population, including the possible role of intermediate hosts. The aim is to prevent both reinfection with the virus in animals and humans and the establishment of new zoonotic reservoirs, thereby reducing further risks of the emergence and transmission of zoonotic diseases

Ergebnisse der Analyse relevanter Einzelprojekte und Maßnahmen mit Gesundheitsbezug im Zeitraum 2014 2018, darauf aufbauende Rückberechnungen für 2000 2013 und Projektionen für 2019 2021 sowie aktuelle Finanzierungszusagen für den Access to COVID 19 Tools Accelerator June 202

My COVID Pass In October 2020, the African Union officially launched the Trusted Travel platform as part of the overall Trusted Travel Initiative during a joint ministerial meeting of the ministers of health, transport, and information and communication of African Union Member States

15 January 2021

Available in English, French, Spanish, Chinese, Russian and Arabic https://apps.who.int/iris/handle/10665/337832